Parida Amitav, Abdel-Mannan Omar, Mankad Kshitij, Foster Katharine, Ramdas Sithara, Ram Dipak, Eleftheriou Despina, Hemingway Cheryl, Hacohen Yael, Wassmer Evangeline
Department of Paediatric Neurology, Birmingham Children's Hospital, Birmingham, UK.
Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, UK/Queen Square MS Centre, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
Mult Scler. 2022 Apr;28(4):669-675. doi: 10.1177/13524585211053565. Epub 2021 Oct 27.
Isolated central nervous system (CNS) presentations of haemophagocytic lymphohistiocytosis (HLH), traditionally a systemic inflammatory condition, have been reported in adults and children. We identified nine patients with a diagnosis of isolated CNS familial hemophagocytic lymphohistiocytosis (fHLH) with symptom onset <18 years of age, and one asymptomatic sibling. Children with atypical chronic/recurrent CNS inflammation should be considered for immunological and genetic panel testing for fHLH even in the absence of any systemic inflammatory features. Despite haematopoietic stem cell transplantation (HSCT) being a mainstay of treatment, treatment failure and high morbidity and mortality post-HSCT suggest that alternative immune therapies may be worth considering.
噬血细胞性淋巴组织细胞增生症(HLH)传统上是一种全身性炎症性疾病,其孤立的中枢神经系统(CNS)表现已在成人和儿童中有所报道。我们确定了9例诊断为孤立性CNS家族性噬血细胞性淋巴组织细胞增生症(fHLH)且症状发作年龄<18岁的患者,以及1名无症状的同胞。即使没有任何全身性炎症特征,对于患有非典型慢性/复发性CNS炎症的儿童,也应考虑进行fHLH的免疫学和基因检测。尽管造血干细胞移植(HSCT)是主要的治疗方法,但HSCT后的治疗失败以及高发病率和死亡率表明,可能值得考虑其他免疫疗法。